Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase-Reference-Cited by-同舟云学术

Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase

Published:2013-02-18 Issue:4 Volume:104 Page:486-494
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Awazu Yoshiko¹,Mizutani Akio²,Nagase Yoshinori³,Tsuchiya Shuntarou⁴,Nakamura Kazuhide²,Kakoi Yuichi²,Kitahara Osamu⁵,Takeuchi Toshiyuki⁶,Yamasaki Seiji⁷,Miyamoto Naoki⁸,Iwata Hidehisa⁷,Miki Hiroshi⁹,Imamura Shinichi²,Hori Akira⁴

Affiliation:

1. Inflammation Drug Discovery Unit; Fujisawa; Japan

2. Oncology Drug Discovery Unit; Fujisawa; Japan

3. Scientific Intelligence, Chief Medical & Scientific Officer office; Osaka; Japan

4. Extra Value Generation & General Medicine Drug Discovery Unit; Fujisawa; Japan

5. Quality Assurance; Fujisawa; Japan

6. Drug Metabolism and Pharmacokinetics Research Laboratories; Fujisawa; Japan

7. Biomolecular Research Laboratories; Fujisawa; Japan

8. Medicinal Chemistry Research Laboratories; Fujisawa; Japan

9. Environment, Health & Safety, Research Administration Department; Takeda Pharmaceutical Company; Fujisawa; Japan

Publisher

Wiley